Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome

BackgroundThe expression of serine protease granzyme-B (GzmB) by circulating CD8+ T lymphocytes has been recently suggested as a biomarker for poor immunotherapy response and severe disability in patients with Neuromyelitis Optica spectrum disorders (NMOSD). In parallel, venous thromboembolism (VTE)...

Full description

Bibliographic Details
Main Authors: Vinícius Oliveira Boldrini, Mariana Rabelo Brito, Raphael Patrício Silva Quintiliano, Lucas Scárdua Silva, Clarissa Lin Yasuda, Fernando Cendes, Alessandro Santos Farias, Alfredo Damasceno
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2023.1208977/full
_version_ 1797741337340018688
author Vinícius Oliveira Boldrini
Vinícius Oliveira Boldrini
Mariana Rabelo Brito
Raphael Patrício Silva Quintiliano
Lucas Scárdua Silva
Lucas Scárdua Silva
Clarissa Lin Yasuda
Clarissa Lin Yasuda
Fernando Cendes
Fernando Cendes
Alessandro Santos Farias
Alessandro Santos Farias
Alfredo Damasceno
Alfredo Damasceno
author_facet Vinícius Oliveira Boldrini
Vinícius Oliveira Boldrini
Mariana Rabelo Brito
Raphael Patrício Silva Quintiliano
Lucas Scárdua Silva
Lucas Scárdua Silva
Clarissa Lin Yasuda
Clarissa Lin Yasuda
Fernando Cendes
Fernando Cendes
Alessandro Santos Farias
Alessandro Santos Farias
Alfredo Damasceno
Alfredo Damasceno
author_sort Vinícius Oliveira Boldrini
collection DOAJ
description BackgroundThe expression of serine protease granzyme-B (GzmB) by circulating CD8+ T lymphocytes has been recently suggested as a biomarker for poor immunotherapy response and severe disability in patients with Neuromyelitis Optica spectrum disorders (NMOSD). In parallel, venous thromboembolism (VTE) has been reported mainly in NMOSD patients exhibiting transverse myelitis.Case presentationHere, we describe an Aquaporin-4 positive (AQP4-positive) NMOSD patient who showed short myelitis (SM) and experienced a fatal pulmonary thromboembolism/lower extremity deep vein thrombosis during anti-CD20 treatment. Flow cytometry analyses from the peripheral blood revealed an enhanced cytotoxic behavior through circulating CD8+GzmB+ T, CD4+GzmB+ T lymphocytes, and residual CD19+GzmB+ B cells.ConclusionsFatal VTE may be a rare outcome, particularly in patients exhibiting SM, and may share poorly understood immunological mechanisms with AQP4-positive NMOSD severity.
first_indexed 2024-03-12T14:25:21Z
format Article
id doaj.art-7ece9f9fc1c44cac976d378cef7931fe
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-03-12T14:25:21Z
publishDate 2023-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-7ece9f9fc1c44cac976d378cef7931fe2023-08-18T07:38:49ZengFrontiers Media S.A.Frontiers in Neurology1664-22952023-08-011410.3389/fneur.2023.12089771208977Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcomeVinícius Oliveira Boldrini0Vinícius Oliveira Boldrini1Mariana Rabelo Brito2Raphael Patrício Silva Quintiliano3Lucas Scárdua Silva4Lucas Scárdua Silva5Clarissa Lin Yasuda6Clarissa Lin Yasuda7Fernando Cendes8Fernando Cendes9Alessandro Santos Farias10Alessandro Santos Farias11Alfredo Damasceno12Alfredo Damasceno13Neuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, São Paulo, BrazilBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, São Paulo, BrazilBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, São Paulo, BrazilNeuroimmunology Unit, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, São Paulo, BrazilNeuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, São Paulo, BrazilBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, São Paulo, BrazilNeuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, São Paulo, BrazilBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, São Paulo, BrazilNeuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, São Paulo, BrazilBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, São Paulo, BrazilNeuroimmunology Unit, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, São Paulo, BrazilAutoimmune Research Laboratory, Department of Genetics, Evolution, Microbiology and Immunology, Institute of Biology, University of Campinas, Campinas, São Paulo, BrazilNeuroimaging Laboratory, Department of Neurology, University of Campinas, Campinas, São Paulo, BrazilBrazilian Institute of Neuroscience and Neurotechnology (BRAINN), University of Campinas, Campinas, São Paulo, BrazilBackgroundThe expression of serine protease granzyme-B (GzmB) by circulating CD8+ T lymphocytes has been recently suggested as a biomarker for poor immunotherapy response and severe disability in patients with Neuromyelitis Optica spectrum disorders (NMOSD). In parallel, venous thromboembolism (VTE) has been reported mainly in NMOSD patients exhibiting transverse myelitis.Case presentationHere, we describe an Aquaporin-4 positive (AQP4-positive) NMOSD patient who showed short myelitis (SM) and experienced a fatal pulmonary thromboembolism/lower extremity deep vein thrombosis during anti-CD20 treatment. Flow cytometry analyses from the peripheral blood revealed an enhanced cytotoxic behavior through circulating CD8+GzmB+ T, CD4+GzmB+ T lymphocytes, and residual CD19+GzmB+ B cells.ConclusionsFatal VTE may be a rare outcome, particularly in patients exhibiting SM, and may share poorly understood immunological mechanisms with AQP4-positive NMOSD severity.https://www.frontiersin.org/articles/10.3389/fneur.2023.1208977/fullDevic's syndromedeep vein thrombosis (DVT)pulmonary thromboembolismT lymphocytesB cellsgranzyme-B
spellingShingle Vinícius Oliveira Boldrini
Vinícius Oliveira Boldrini
Mariana Rabelo Brito
Raphael Patrício Silva Quintiliano
Lucas Scárdua Silva
Lucas Scárdua Silva
Clarissa Lin Yasuda
Clarissa Lin Yasuda
Fernando Cendes
Fernando Cendes
Alessandro Santos Farias
Alessandro Santos Farias
Alfredo Damasceno
Alfredo Damasceno
Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome
Frontiers in Neurology
Devic's syndrome
deep vein thrombosis (DVT)
pulmonary thromboembolism
T lymphocytes
B cells
granzyme-B
title Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome
title_full Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome
title_fullStr Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome
title_full_unstemmed Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome
title_short Case report: Granzyme-B expression by T- and B- cells during severe AQP4-positive Neuromyelitis Optica spectrum disorder with fatal venous thromboembolism outcome
title_sort case report granzyme b expression by t and b cells during severe aqp4 positive neuromyelitis optica spectrum disorder with fatal venous thromboembolism outcome
topic Devic's syndrome
deep vein thrombosis (DVT)
pulmonary thromboembolism
T lymphocytes
B cells
granzyme-B
url https://www.frontiersin.org/articles/10.3389/fneur.2023.1208977/full
work_keys_str_mv AT viniciusoliveiraboldrini casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT viniciusoliveiraboldrini casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT marianarabelobrito casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT raphaelpatriciosilvaquintiliano casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT lucasscarduasilva casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT lucasscarduasilva casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT clarissalinyasuda casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT clarissalinyasuda casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT fernandocendes casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT fernandocendes casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT alessandrosantosfarias casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT alessandrosantosfarias casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT alfredodamasceno casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome
AT alfredodamasceno casereportgranzymebexpressionbytandbcellsduringsevereaqp4positiveneuromyelitisopticaspectrumdisorderwithfatalvenousthromboembolismoutcome